FDA PDUFA Calendar: Drug Approval Dates & Deadlines
Track FDA PDUFA dates for NDA, BLA, ANDA, and IND decisions. Free drug approval tracker with source-linked deadlines, calendar views, and daily updates.
Published PDUFA target action dates for NDAs, BLAs, ANDAs, and INDs scheduled in the next 90 days, sourced from FDA primary records and updated daily.
Tracking 32 published FDA PDUFA decisions, including 18 NDAs and 14 BLAs.
| Sponsor | Product | Type | Application | PDUFA date | Status | Expand and copy |
|---|---|---|---|---|---|---|
| Celcuity | gedatolisib | NDA | PENDING-provisional|celcuity|gedatolisib|hrpositiveher2n | upcoming | ||
| Elevar Therapeutics | rivoceranib + camrelizumab | NDA | PENDING-provisional|elevartherapeutics|rivoceranibcamrel | upcoming | ||
| Sanofi | Sarclisa SC | BLA | PENDING-provisional|sanofi|sarclisasc|multiplemyeloma|20 | upcoming | ||
| Otsuka Pharmaceutical | centanafadine | NDA | PENDING-provisional|otsukapharmaceutical|centanafadine|a | upcoming | ||
| MannKind | FUROSCIX ReadyFlow Autoinjector | NDA | PENDING-provisional|mannkind|furoscixreadyflowautoinject | upcoming | ||
| Outlook Therapeutics, Inc. | ONS-5010 (bevacizumab-vikg) / LYTENAVA | BLA | PENDING-provisional|outlooktherapeuticsinc|ons5010bevaci | upcoming | ||
| Viatris | low-dose estrogen weekly patch | NDA | PENDING-provisional|viatris|lowdoseestrogenweeklypatch|c | upcoming | ||
| Replimune Group | RP1 (vusolimogene oderparepvec) | BLA | PENDING-provisional|replimunegroup|rp1vusolimogeneoderpa | upcoming | ||
| Moderna | mRNA-1010 | BLA | PENDING-provisional|moderna|mrna1010|seasonalinfluenzapr | upcoming | ||
| Lantheus | MK-6240 | NDA | PENDING-provisional|lantheus|mk6240|petimagingagenttarge | upcoming | ||
| Bristol Myers Squibb | iberdomide + daratumumab/dexamethasone | NDA | PENDING-provisional|bristolmyerssquibb|iberdomidedaratum | upcoming | ||
| Merck, Astellas, and Pfizer | KEYTRUDA + PADCEV | BLA | PENDING-provisional|merckastellasandpfizer|keytrudapadce | upcoming | ||
| Capricor Therapeutics | deramiocel | BLA | PENDING-provisional|capricortherapeutics|deramiocel|duch | upcoming | ||
| Ultragenyx Pharmaceutical | DTX401 | BLA | PENDING-provisional|ultragenyxpharmaceutical|dtx401|glyc | upcoming | ||
| Eisai and Biogen | LEQEMBI IQLIK | BLA | PENDING-provisional|eisaiandbiogen|leqembiiqlik|subcutan | upcoming | ||
| Jazz Pharmaceuticals | Ziihera | BLA | PENDING-provisional|jazzpharmaceuticals|ziihera|firstlin | upcoming | ||
| Gilead Sciences | bictegravir/lenacapavir | NDA | PENDING-provisional|gileadsciences|bictegravirlenacapavi | upcoming | ||
| ITM Isotope Technologies Munich | 177Lu-edotreotide | NDA | PENDING-provisional|itmisotopetechnologiesmunich|177lued | upcoming | ||
| PharmaEssentia | BESREMi | BLA | PENDING-provisional|pharmaessentia|besremi|essentialthro | upcoming | ||
| Advicenne | Sibnayal | NDA | PENDING-provisional|advicenne|sibnayal|distalrenaltubula | upcoming | ||
| Telix Pharmaceuticals | TLX101-Px (Pixclara) | NDA | PENDING-provisional|telixpharmaceuticals|tlx101pxpixclar | upcoming | ||
| Nuvalent | zidesamtinib | NDA | PENDING-provisional|nuvalent|zidesamtinib|ros1positiveno | upcoming | ||
| Ultragenyx Pharmaceutical | UX111 | BLA | PENDING-provisional|ultragenyxpharmaceutical|ux111|sanfi | upcoming | ||
| Merck | WINREVAIR | BLA | PENDING-provisional|merck|winrevair|pulmonaryarterialhyp | upcoming | ||
| Ionis Pharmaceuticals | zilganersen | NDA | PENDING-provisional|ionispharmaceuticals|zilganersen|ale | upcoming | ||
| Incyte Corporation / Mirum Pharmaceuticals | Zilurgisertib | NDA | PENDING-provisional|incytecorporationmirumpharmaceutical | upcoming | ||
| Praxis Precision Medicines | relutrigine | NDA | PENDING-provisional|praxisprecisionmedicines|relutrigine | upcoming | ||
| Biofrontera | Ameluz-PDT | NDA | PENDING-provisional|biofrontera|ameluzpdt|superficialbas | upcoming | ||
| Egetis Therapeutics | Emcitate (tiratricol) | NDA | PENDING-provisional|egetistherapeutics|emcitatetiratrico | upcoming | ||
| Scholar Rock | apitegromab | BLA | PENDING-provisional|scholarrock|apitegromab|spinalmuscul | upcoming | ||
| Merck and Eisai | WELIREG + LENVIMA | NDA | PENDING-provisional|merckandeisai|welireglenvima|advance | upcoming | ||
| Daiichi Sankyo and Merck | ifinatamab deruxtecan | BLA | PENDING-provisional|daiichisankyoandmerck|ifinatamabderu | upcoming |
Select any row to expand its full record. Use the calendar, timeline, status board, or table views above to filter, sort, and inspect source-linked details.
Track FDA PDUFA dates for NDA, BLA, ANDA, and IND decisions. Free drug approval tracker with source-linked deadlines, calendar views, and daily updates.